Vai al contenuto principale
Italiano
English
Login
Department of Drug Science and Technology
Department of Drug Science and Technology
search
menu
Follow us
Discord
Facebook
Cerca:
Search in:
Advanced search
Throughout the site
Notices
Staff
Discord
Facebook
Home
About us
About the Department
Contacts us
People
Organisation
Facilities
Library and bibliographic heritage
Classrooms
Study with us
Programs
Further education courses
Students' mobility
Tutoring and student support
UNITA - Virtual Mobility
Research
Research Areas and Groups
Research Projects
PhD
Teacher and Researchers' Mobility
Publications
Research equipment
Patents
Spin-off
Awards and Recognitions
Conferences, workshop and training
Public engagement
Info for
Home
About us
arrow_drop_down
About the Department
Contacts us
People
Organisation
Facilities
arrow_drop_down
Library and bibliographic heritage
Classrooms
Study with us
arrow_drop_down
Programs
Further education courses
Students' mobility
Tutoring and student support
UNITA - Virtual Mobility
Research
arrow_drop_down
Research Areas and Groups
Research Projects
PhD
Teacher and Researchers' Mobility
Publications
Research equipment
Patents
Spin-off
Awards and Recognitions
Conferences, workshop and training
Public engagement
Info for
Home
Staff
Daniele Zonari
Daniele Zonari
Technical and administrative staff
Department of Drug Science and Technology
ORCID:
orcid.org/0000-0002-1148-5408
Contacts
Teaching
Research
Research products
Third mission
Activities
Office hours
Announcements
Other content
Contacts
0116706667
daniele.zonari@unito.it
Via Pietro Giuria, 9 - Torino
https://www.dstfen.unito.it/persone/daniele.zonari
Contacts VCard
Contacts QRcode
At
Department of Drug Science and Technology
Dipartimento di Scienza e Tecnologia del Farmaco
Research products
All my research products
Research projects
Active targeting of squalene nanoassemblies against cancer and theranostic approach (Active-SQ-NP)
Anticancer drugs-loading into new mesoporous silica nanoparticles (Anti Cancer Drugs New-MSN-)
Potent anticancer prodrugs able to self-assemble after conjugation with squalene moiety. Role of the releasing spacer (Next-SQ-CancerDrugs)
Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells
Home
Print
Last update: 21/07/2023 10:11
Inizio pagina
Non cliccare qui!
